GENOTYPIC RESISTANCE REDUCED TO VERY LOW LEVELS IN CHRONIC HEPATITIS B (CHB) PATIENTS TREATED OVER 2-YEARS WITH TELBIVUDINE (LDT) WHEN CONSIDERING BASELINE CHARACTERISTICS AND ROADMAP
单位：[1]INSERM, Viral Hepatitis Res Team, F-69008 Lyon, France[2]Klinikum Johann Wolfgang Goethe Univ, Frankfurt, Germany[3]Songklanagarind Hosp, NKC Inst Gastroenterol & Hepatol, Bangkok, Thailand[4]Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China[5]Beijing Friendship Hosp, Beijing, Peoples R China首都医科大学附属北京友谊医院[6]So Med Univ, Guangzhou, Guangdong, Peoples R China[7]Novartis Pharma AG, Basel, Switzerland[8]Novartis Pharmaceut, E Hanover, NJ USA
第一作者单位：[1]INSERM, Viral Hepatitis Res Team, F-69008 Lyon, France
推荐引用方式(GB/T 7714)：
Zoulim F.,Zeuzem S.,Piratvisuth T.,et al.GENOTYPIC RESISTANCE REDUCED TO VERY LOW LEVELS IN CHRONIC HEPATITIS B (CHB) PATIENTS TREATED OVER 2-YEARS WITH TELBIVUDINE (LDT) WHEN CONSIDERING BASELINE CHARACTERISTICS AND ROADMAP[J].JOURNAL of HEPATOLOGY.2012,56:S195-S195.doi:10.1016/S0168-8278(12)60509-1.
APA：
Zoulim, F.,Zeuzem, S.,Piratvisuth, T.,Chan, H. L.,Hou, J....&Trylesinski, A..(2012).GENOTYPIC RESISTANCE REDUCED TO VERY LOW LEVELS IN CHRONIC HEPATITIS B (CHB) PATIENTS TREATED OVER 2-YEARS WITH TELBIVUDINE (LDT) WHEN CONSIDERING BASELINE CHARACTERISTICS AND ROADMAP.JOURNAL of HEPATOLOGY,56,
MLA：
Zoulim, F.,et al."GENOTYPIC RESISTANCE REDUCED TO VERY LOW LEVELS IN CHRONIC HEPATITIS B (CHB) PATIENTS TREATED OVER 2-YEARS WITH TELBIVUDINE (LDT) WHEN CONSIDERING BASELINE CHARACTERISTICS AND ROADMAP".JOURNAL of HEPATOLOGY 56.(2012):S195-S195
医学